Patient-derived tumoroids and proteomic signatures: tools for early drug discovery

Patient-derived tumoroids and proteomic signatures: tools for early drug discovery

Onco-virotherapy is an emergent treatment for cancer based on viral vectors. The therapeutic activity is based on two different mechanisms including tumor-specific oncolysis and immunostimulatory properties. In this study, we evaluated onco-virotherapy in vitro responses on immunocompetent non-small...

Full description

Bibliographic Details
Main Authors: Hélène Lê, Jules Deforges, Pasquale Cutolo, Anissa Lamarque, Guoqiang Hua, Véronique Lindner, Shreyansh Jain, Jean-Marc Balloul, Nadia Benkirane-Jessel, Eric Quéméneur
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Immunology
Subjects:
onco-virotherapy
Anti-cancer Therapy
immuno-oncology
non-small-cell lung cancer
patient-derived tumoroids
proteomic
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1379613/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1379613/full

Similar Items